NCT07034053View on ClinicalTrials.gov

Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Advanced Urothelial CarcinomaMetastatic Urothelial Cancer
Interventions
DRUG

Clofarabine

Patients receive i.v. clofarabine in a dose-escalation regimen

Trial Locations (1)

1090

RECRUITING

Department of Urology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Ekaterina Laukhtina

OTHER